Effect of L-Ergothioneine on the metabolic plasma profile of the RUPP rat model of pre-eclampsia

Autor: Douglas B. Kell, Fergus P. McCarthy, Rachel D. Williamson, Aude-Claire Morillon, Louise C. Kenny, Philip N. Baker, Jane A. English, Cathal McCarthy
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Antioxidant
Maternal Health
medicine.medical_treatment
Metabolite
030204 cardiovascular system & hematology
medicine.disease_cause
Biochemistry
Rats
Sprague-Dawley

chemistry.chemical_compound
0302 clinical medicine
Pre-Eclampsia
Pregnancy
Metabolites
Medicine and Health Sciences
Energy-Producing Organelles
Multidisciplinary
Organic Compounds
Chemistry
Obstetrics and Gynecology
Lipids
Mitochondria
3. Good health
Perfusion
Physical Sciences
Purine Metabolism
Metabolome
Medicine
Steroids
Female
Metabolic Pathways
Cellular Structures and Organelles
medicine.symptom
Research Article
medicine.medical_specialty
Science
Inflammation
Bioenergetics
Preeclampsia
03 medical and health sciences
In vivo
Internal medicine
Pressure
medicine
Animals
Sphingolipids
Fetus
Organic Chemistry
Chemical Compounds
Biology and Life Sciences
Ergothioneine
Cell Biology
medicine.disease
Rats
Amino Acid Metabolism
Pregnancy Complications
Disease Models
Animal

Metabolism
030104 developmental biology
Endocrinology
Women's Health
Oxidative stress
Zdroj: PLoS ONE, Vol 15, Iss 3, p e0230977 (2020)
Morillon, A C, Williamson, R D, Baker, P N, Kell, D B, Kenny, L C, English, J A, McCarthy, F P & McCarthy, C 2020, ' Effect of L-Ergothioneine on the metabolic plasma profile of the RUPP rat model of preeclampsia ', PLOS ONE, vol. 15, no. 3, e0230977 . https://doi.org/10.1371/journal.pone.0230977
PLoS ONE
ISSN: 1932-6203
Popis: IntroductionPre-eclampsia is a major cause of maternal and fetal mortality and morbidity worldwide. Its pathophysiology remains unclear, but mitochondrial dysfunction and oxidative stress have been implicated. L-Ergothioneine is a naturally occurring, water-soluble betaine, that has demonstrated antioxidant properties. Using the reduced uterine perfusion pressure (RUPP) rat model of pre-eclampsia, this study aimed to define the plasma metabolic profile following treatment with L-Ergothioneine.MethodsThe effect of L-Ergothioneine (ET) treatment was explored using in vivo treatment in rats: Sham control (SC, n = 5), RUPP control (RC, n = 5), Sham +ET (ST, n = 5), RUPP +ET (RT, n = 5). Differential expression of plasma metabolites were obtained using untargeted liquid chromatography coupled to mass spectrometry. Statistical analysis was performed on normalised data comparing RC to SC, RT to RC, and RT to ST. Metabolites significantly altered (FDR < 0.05) were identified through database search.ResultsWe report significantly lower levels of L-palmitoylcarnitine in RC compared to SC, a fatty acyl substrate involved in beta-oxidation in the mitochondria. We report that a metabolite that has been associated with oxidative stress (Glutamylcysteine) was detected at significantly higher levels in RT vs RC and RT vs ST. Five metabolites associated with inflammation were significantly lower in RT vs RC and three metabolites in RT vs ST, demonstrating the anti-inflammatory effects of ET in the RUPP rat model of pre-eclampsia.ConclusionsL-Ergothioneine may help preserve mitochondrial function by increasing antioxidant levels, and reducing inflammatory responses associated with pre-eclampsia. This study shows the potential of L-Ergothioneine as a treatment for pre-eclampsia.
Databáze: OpenAIRE